Thus, given that cancer progression and functional deterioration are among the two main causes of mortality in patients with HCC, our findings confirm again the important role of VEGF as a key driver of angiogenesis involving the entire process of liver disease progression. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.